Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A

NCT02027779 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT02027779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02027779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2014
Completion date
February 29, 2016
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a